Vaccine

Details for Australian Patent Application No. 2008333208 (hide)

Owner GlaxoSmithKline Biologicals S.A.

Inventors Cohen, Joseph D.; Marchand, Martine

Agent Shelston IP

Pub. Number AU-A-2008333208

PCT Pub. Number WO2009/071613

Priority 60/992,802 06.12.07 US

Filing date 4 December 2008

Wipo publication date 11 June 2009

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/015 (2006.01) Medicinal preparations containing antigens or antibodies

A61P 33/06 (2006.01) Antiparasitic agents

C12N 15/861 (2006.01) Mutation or genetic engineering - Adenoviral vectors

Event Publications

17 June 2010 PCT application entered the National Phase

  PCT publication WO2009/071613 Priority application(s): WO2009/071613

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008333215-Use of 3-(indolyl)- or 3-(azaindolyl)-4-arylmaleimide derivatives in leukemia management

2008333201-Organic compounds